: FDA pulls preterm-birth drug Makena and its generics from market after 12 years

The U.S. Food and Drug Administration said Thursday it had reached a final decision to fully withdraw approval of preterm-birth drug Makena and its generics, a full 12 years after the treatment hit the market.

The drug was approved in 2011 using the agency’s accelerated-approval pathway as a treatment to reduce the risk of spontaneous preterm birth in pregnant women who had a history of the condition.

The…

This post was originally published on Market Watch

Share:

Futurist Eric Fry says it will be a “Summer of Surge” for these three stocks

One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Watch now…

Latest News

Daily News on Investing, Personal Finance, Markets, and more!

Financial News

Financial News

Policy(Required)

Financial News

Daily News on Investing, Personal Finance, Markets, and more!

Financial News

Policy(Required)